MESO CIK: 1345099

Mesoblast Ltd Sponsored ADR

  • Australia
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY23 to FY25
millions USD
FY21:
–
FY22:
–
FY23:
7.50
FY24:
5.90
FY25:
12.1
(positive)
Change from FY21 to FY25
millions USD
FY21:
−108
FY22:
−81.1
FY23:
−69.3
FY24:
−58.0
FY25:
−62.0
(positive)
Change from FY21 to FY25
millions USD
FY21:
−103
FY22:
−76.7
FY23:
−64.4
FY24:
−51.5
FY25:
−59.7
(positive)
Change from FY21 to FY25
millions USD
FY21:
−99.6
FY22:
−91.6
FY23:
−82.1
FY24:
−88.1
FY25:
−102
(positive)
Change from FY21 to FY25
millions USD
FY21:
−98.8
FY22:
−91.3
FY23:
−81.9
FY24:
−88.0
FY25:
−102

All amounts in millions USD Data sources:SEC EDGARTwelve Data